ArticleFrontiers in endocrinology2025
Liver fibrosis assessed via noninvasive liver fibrosis scores is associated with atherosclerotic cardiovascular disease in middle-aged and older patients with prediabetes.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metabolic dysfunction-associated steatotic liver disease-related liver fibrosis is linked to an increased risk of atherosclerotic cardiovascular disease (ASCVD); however, its impact on patients with prediabetes remains unclear. The aim of our study was to investigate the associations between ASCVD and three noninvasive liver fibrosis scores, including the fibrosis-4 index (FIB-4), nonalcoholic fatty liver disease fibrosis score (NFS), and aspartate aminotransferase-to-platelet ratio index (APRI), in middle-aged and older patients with prediabetes. Methods: In this cross-sectional study, a total of 7,409 patients with prediabetes aged 40 to 80 years were classified into two groups based on their ASCVD statuses. Logistic regression analysis was performed to explore the relationships between liver fibrosis scores and ASCVD. Restricted cubic spline (RCS) curves were employed to explore potential nonlinear relationships. The performances of the liver fibrosis scores were compared using receiver operating characteristic (ROC) curves. Results: Noninvasive liver fibrosis scores, including FIB-4, NFS, and APRI values, were independently associated with an increased likelihood of having ASCVD in middle-aged and older patients with prediabetes. After adjusting for confounding factors, the patients in the high-risk FIB-4, NFS, and APRI groups had 1.5, 2.6, and 1.5 times the odds of ASCVD, respectively, compared with those in the low-risk groups, with odds ratios and 95% confidence intervals of 1.497 (1.089-2.055) for FIB-4 (P = 0.013), 2.632 (1.949-3.560) for NFS (P < 0.001), and 1.483 (1.092-2.002) for APRI (P = 0.011). RCS analysis revealed a nonlinear positive correlation between FIB-4 and ASCVD, whereas the relationships between NFS and ASCVD and between APRI and ASCVD were approximately linear. In the ROC curve analysis, both FIB-4 and NFS exhibited area under the curve values exceeding 0.7 in detecting individuals with ASCVD, whereas APRI was a relatively poor discriminator of ASCVD. Conclusions: Liver fibrosis assessed via noninvasive indices was significantly positively associated with an increased risk of ASCVD in middle-aged and older patients with prediabetes, thereby underscoring the value of liver fibrosis scores as reliable indicators for identifying the presence of ASCVD in individuals with prediabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.